社会经济地位与儿童出院后医疗资源使用及生活质量的相关性
共958例完成资源使用访谈,750例完成生活质量问卷。与高收入患儿相比,低收入患儿接受的医疗服务提供者类型更少(β=-0.4; p=0.004)、新处方医疗设备使用更少(OR=0.4; p<0.001)、急诊就诊更多(43% vs 33%; p=0.04);<2岁低收入患儿体能评分低8.6分(p=0.01)、身体疼痛/不适评分高8.2分(p<0.05)。医疗资源使用越多者生活质量越低。提示需关注低收入患儿的持续随访。
要点
- 急性呼吸衰竭患儿出院后仍有持续的居家护理、药物、设备、急诊和再住院等医疗资源使用。
- 低收入患儿较高收入患儿接受的医疗服务提供者类型更少(β=-0.4; p=0.004),新处方医疗设备更少(OR=0.4; p<0.001)。
- 低收入患儿急诊就诊比例更高(43% vs 33%; p=0.04),提示其可能更多依赖医院资源。
- <2岁低收入患儿生活质量中体能评分低8.6分(p=0.01),身体疼痛/不适评分高8.2分(p<0.05)。
- 医疗服务提供者数量、处方药物、急诊就诊或再住院越多,患儿健康相关生活质量越低。
适用人群与场景
- 场景:PICU出院后随访阶段,非急诊或ICU急性期。
- 排除:原文未提及具体排除标准。
诊断标准与关键阈值
- 社会经济地位:通过将居住地址匹配至普查区中位收入进行估计,分为低收入与高收入。
- 资源使用:包括居家护理、医疗服务提供者数量、处方药物、家用医疗设备、急诊就诊和再住院。
- 生活质量:使用基于年龄的家长报告量表评估。
- 原文未提及具体的收入界值或生活质量评分界值。
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径或处置流程。
- 原文建议:对低收入患儿尤其应持续随访,以识别需要持续医疗资源或存在生活质量下降风险的患儿。
红旗征与不能漏的情况
- 原文未提及需要立刻处理或不能漏诊的红旗征。
研究设计与关键结果
- 人群:急性呼吸衰竭患儿;干预/暴露:按普查区中位收入估计的社会经济地位(低收入 vs 高收入)。
- 主要结果:低收入患儿接受的医疗服务提供者类型更少(β=-0.4; p=0.004),新处方医疗设备更少(OR=0.4; p<0.001),急诊就诊更多(43% vs 33%; p=0.04)。
- 生活质量:<2岁低收入患儿体能评分低8.6分(p=0.01),身体疼痛/不适评分高8.2分(p<0.05);医疗服务提供者更多、处方药物更多者生活质量更低;年长儿中处方药物、急诊就诊或再住院者生活质量更低。
- 原文未提及关键次要终点的95%CI、NNT或不良事件数据。
证据类型、等级与局限
- 证据类型:随机对照试验(RESTORE)的二次分析。
- 证据等级或推荐强度:原文未提及。
- 局限:二次分析;社会经济地位基于普查区中位收入估计而非个体收入;资源使用和生活质量依赖家长报告;原文未提及随访时长和失访情况。
对床旁实践的改变
- 提示急诊/ICU团队在急性呼吸衰竭患儿出院时应关注社会经济地位,对低收入患儿尤其应安排持续随访。
- 低收入患儿可能较少使用居家和门诊服务而更多使用急诊资源,随访中应主动评估其居家护理、设备和药物可及性。
- 对存在多种医疗服务提供者、多种处方药物、急诊就诊或再住院的患儿,应关注生活质量下降风险。
- 适用人群:急性呼吸衰竭PICU存活患儿;不适用人群:原文未提及。
- 常见陷阱:不能将普查区中位收入等同于个体收入;不能将相关性结果作为因果推断。
指南或共识出处
- 原文未提及指南或共识名称;研究基于Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE)临床试验数据。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Socioeconomic factors may impact healthcare resource use and health-related quality of life, but their association with postcritical illness outcomes is unknown. This study examines the associations between socioeconomic status, resource use, and health-related quality of life in a cohort of children recovering from acute respiratory failure.
DESIGN: Secondary analysis of data from the Randomized Evaluation of Sedation Titration for Respiratory Failure clinical trial.
SETTING: Thirty-one PICUs.
PATIENTS: Children with acute respiratory failure enrolled whose parent/guardians consented for follow-up.
MEASUREMENTS AND MAIN RESULTS: Resource use included in-home care, number of healthcare providers, prescribed medications, home medical equipment, emergency department visits, and hospital readmission. Socioeconomic status was estimated by matching residential address to census tract-based median income. Health-related quality of life was measured using age-based parent-report instruments. Resource use interviews with matched census tract data (n = 958) and health-related quality of life questionnaires (n = 750/958) were assessed. Compared with high-income children, low-income children received care from fewer types of healthcare providers (β = -0.4; p = 0.004), used less newly prescribed medical equipment (odds ratio = 0.4; p < 0.001), and had more emergency department visits (43% vs 33%; p = 0.04). In the youngest cohort (< 2 yr old), low-income children had lower quality of life scores from physical ability (-8.6 points; p = 0.01) and bodily pain/discomfort (+8.2 points; p < 0.05). In addition, health-related quality of life was lower in those who had more healthcare providers and prescribed medications. In older children, health-related quality of life was lower if they had prescribed medications, emergency department visits, or hospital readmission.
CONCLUSIONS: Children recovering from acute respiratory failure have ongoing healthcare resource use. Yet, lower income children use less in-home and outpatient services and use more hospital resources. Continued follow-up care, especially in lower income children, may help identify those in need of ongoing healthcare resources and those at-risk for decreased health-related quality of life.
参考来源
- Kachmar AG, Watson RS, Wypij D, et al. Association of Socioeconomic Status With Postdischarge Pediatric Resource Use and Quality of Life. Crit Care Med. 2022. PMID: 34495879. doi:10.1097/CCM.0000000000005261
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。